Efficacy and Safety of Sequential Monotherapy of Ticagrelor and Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention With Acute Coronary Syndrome
Latest Information Update: 09 May 2023
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms MATE
- 02 May 2023 Planned End Date changed from 1 Jun 2025 to 31 Dec 2025.
- 02 May 2023 Planned primary completion date changed from 1 Jun 2024 to 31 Dec 2025.
- 02 May 2023 Status changed from not yet recruiting to recruiting.